REN-850 Uses, Dosage, Side Effects and more
REN-850 is an oral drug for multiple sclerosis which is in Phase I of clinical trials.
Trade Name | REN-850 |
Generic | REN-850 |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in multiple sclerosis.
How REN-850 works
REN-850 acts by inhibiting leukocyte trafficking and modulating the cell migration driven by multiple chemokine receptors. The oral administration of REN-850 significantly reduces severity of outcomes in multiple in vivo models of multiple Sclerosis (MS) and rheumatoid arthritis (RA).